Cargando…
Pharmacogenetic guidance: individualized medicine promotes enhanced pain outcomes
The use of pharmacogenomics has become more prevalent over the past several years in treating many disease states. Several cytochrome P450 enzymes play a role in the metabolism of many pain medications including opioids and antidepressants. Noncytochrome P450 enzymes such as methylenetetrahydrofolat...
Autores principales: | Dragic, Lisa Lynn, Wegrzyn, Erica L, Schatman, Michael E, Fudin, Jeffrey |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5743122/ https://www.ncbi.nlm.nih.gov/pubmed/29317847 http://dx.doi.org/10.2147/JPR.S144560 |
Ejemplares similares
-
Fact or fiction: the truth behind the doctors company claims regarding licit and illicit opioids
por: Dragic, Lisa Lynn, et al.
Publicado: (2018) -
Safety concerns with the Centers for Disease Control opioid calculator
por: Fudin, Jeffrey, et al.
Publicado: (2017) -
Fentalogues
por: Persico, Amelia L, et al.
Publicado: (2020) -
The Repeal of the Affordable Care Act and Its Likely Impact on Chronic Pain Patients: “Have You No Shame?”
por: Schatman, Michael E, et al.
Publicado: (2020) -
The MEDD myth: the impact of pseudoscience on pain research and prescribing-guideline development
por: Fudin, Jeffrey, et al.
Publicado: (2016)